FAS/FAS ligand expression and induction of apoptosis in chondrocytes
Open Access
- 1 October 1997
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (10), 1749-1755
- https://doi.org/10.1002/art.1780401004
Abstract
Objective. To examine the expression of Fas/Fas ligand and the role of this ligand/receptor interaction in the regulation of apoptosis in normal human articular chondrocytes and in osteoarthritis (OA) cartilage. Methods. Normal and OA human knee cartilage and cells isolated from these tissues were tested for Fas expression by flow cytometry. Induction of apoptosis by antibody to Fas was analyzed by DAPI staining and electron microscopy. Results. Treatment of freshly isolated normal human articular chondrocytes with an agonistic Fas antibody induced apoptosis in a subpopulation (‐20%) of the cells. Apoptosis induced by anti‐Fas was not dependent on nitric oxide (NO), and anti‐Fas also did not induce NO production. Analysis of isolated cells demonstrated similar levels of Fas expression on normal and OA chondrocytes (28% and 32%, respectively). In normal articular cartilage, Fas‐positive cells were located mainly in the superficial and midzones. In contrast, in fibrillated OA cartilage, surface layers were partially absent and Fas‐expressing cells were also detected in the deeper layers. Fas ligand messenger RNA was not detectable in resting or activated normal or OA chondrocytes. Analysis by electron microscopy showed the nuclear and cytoplasmic changes typical of apoptosis in cultures treated with antibody to Fas. Conclusion. A subpopulation of chondrocytes expresses Fas and is susceptible to Fas‐induced apoptosis. Fas‐mediated chondrocyte apoptosis may contribute to cartilage degradation in arthritis.Keywords
This publication has 22 references indexed in Scilit:
- Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice.Journal of Clinical Investigation, 1996
- The superficial layer of human articular cartilage is more susceptible to interleukin‐1–induced damage than the deeper layersArthritis & Rheumatism, 1996
- FAS Antigen Expression on Synovial Cells Was Down-Regulated by Interleukin 1βBiochemical and Biophysical Research Communications, 1996
- Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationNature, 1995
- Clinical implications of osteoarthritis and ageing.Annals Of The Rheumatic Diseases, 1995
- Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis CHepatology, 1994
- The mouse fas-ligand gene is mutated in gld mice and is part of a TNF family gene clusterImmunity, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Interactions of synovial fluid immunoglobulins with chondrocytesArthritis & Rheumatism, 1992
- Arthritis and agingCurrent Opinion in Rheumatology, 1992